Mayo Clinic at American Association of Cancer Research

Mayo Clinic Cancer Center researchers will describe significant findings across the spectrum of cancer research at the 2007 meeting of the American Association for Cancer Research (AACR).

These findings include advancing research towards a breast cancer vaccine, identifying a prognostic protein for a rare cancer, and discovering a wood mold by-product with the potential to treat myeloma. Mayo Clinic Cancer Center's researchers also have learned that chronic allergens contribute to cancer metastasis to the lungs, and that aspirin use can be correlated to decreased incidence of cancer.

From studies reviewing basic laboratory science, to clinical trials and the final translation of that research to individualized patient care, Mayo Clinic Cancer Center has a broad portfolio of presentations at the 2007 AACR meeting. Other presentations include findings on the most prevalent and deadly cancers, including breast, lung, ovarian, and prostate cancers and other common and rare tumor types, and several blood cancers. More than 40 oral abstracts, numerous poster displays and several special sessions are being presented by investigators from Mayo's sites in Arizona, Florida and Minnesota.

Check back at this site throughout the week to learn about Mayo research and discoveries being announced during scientific sessions at AACR's annual meeting.

Featured Mayo Clinic Presentations

Sunday, April 15

Mayo Clinic Cancer Center Finds Mold Byproduct Kills Multiple Myeloma
Mayo Clinic Cancer Center researchers have found that chaetocin, a by-product of a common wood mold, has promise as a new anti-myeloma agent. Results of their study are being presented today at the American Association for Cancer Research annual meeting. Read more.

Tuesday, April 17

Mayo Clinic Cancer Center — Finding Ways to Lessen Health Disparities
Prognostic enzyme for nasopharyngeal cancer identified.
Mayo Clinic Cancer Center scientists, in collaboration with Chinese researchers, have isolated an enzyme that could be used to predict survival and recurrence rates for nasopharyngeal cancer — one of the most prevalent cancers affecting people from Southeast Asia. Read more.

American Association for Cancer Research Cancer Tip: Of Asthma and Aspirin, Two Studies Highlight Role of Inflammation in Cancer
Can reducing inflammation keep cancer at bay? Two novel studies presented at the 2007 Annual Meeting of the American Association for Cancer Research that examine use of common anti-inflammatory agents suggest this might be the case. One large study found that women who regularly use aspirin developed fewer cancers than women who did not, while another, conducted in mice and now being confirmed in an analysis of breast cancer patient records, discovered a link between asthma and an increased risk of cancer metastasis to the lungs. Read more.

• Questions and Answers Related to Study of Anti-inflammatory Agents
• Questions and Answers Related to Study of Link Between Asthma and Cancer Metastasis

Breast Cancer Vaccine Stimulates Potent Immune Response to Cancer Cells
A cancer study lost to Hurricane Katrina and recovered at Mayo Clinic in Rochester, Minn., will be presented April 17 at the American Association for Cancer Research (AACR) annual meeting. The research describes a new strategy in the promising field of cancer vaccine research that may prove to be more successful than methods currently under study and in clinical trials. Read more.